Home

About

Advanced Search

Browse by Discipline

Scientific Societies

E-print Alerts

Add E-prints

E-print Network
FAQHELPSITE MAPCONTACT US


  Advanced Search  

 
antibody therapy with rituximab. Although rituximab has gained increasing
 

Summary: antibody therapy with rituximab.
Although rituximab has gained increasing
use in the therapy of extranodal marginal
zone lymphomas of MALT type, the
curative potential of this modality is
unknown. Further studies are necessary
to advance our understanding of the role
of antibiotic or antiviral therapy for this
entity.
Competing interests: None.
Br J Ophthalmol 2008;92:446448.
doi:10.1136/bjo.2007.134965
REFERENCES
1. Coupland SE, Damato B. Lymphomas involving the
eye and the ocular adnexa. Curr Opin Ophthalmol
2006;17:52331.
2. Isaacson P, Wright DH. Malignant lymphoma of
mucosa-associated lymphoid tissue. A distinctive type
of B-cell lymphoma. Cancer 1983;52:14106.
3. Suarez F, Lortholary O, Hermine O, et al. Infection-

  

Source: Abecasis, Goncalo - Department of Biostatistics, University of Michigan

 

Collections: Biology and Medicine; Mathematics